Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00644553 | Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis | PHASE3 | COMPLETED | 437 | — | — | May 1, 2003 | - | Mar 27, 2008 | 53 | United States, Canada +7 |
| Arm | Type | Description |
|---|---|---|
| A | ACTIVE_COMPARATOR | - |
| B | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Clarithromycin | DRUG | Clarithromycin Extended-Release 500 mg tablet (2 tablets QD) |
| Amoxicillin | DRUG | Amoxicillin-clavulanate 875/125 mg tablet (1 tablet BID) |
Inclusion Criteria: * The female must be non-lactating and at no risk for pregnancy. * Subject must have a diagnosis of ABS. The diagnosis must be based on the following: * A sinus radiograph (Water's view) or CT scan with evidence of maxillary opacification or * Air/fluid levels purulent disc...